1-2 of 2
Ke Tan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High HDAC I/IIb selective inhibitor purinostat mesylate in relapsed and refractory peripheral T-cell lymphoma: A single-agent phase IIa study

Free
Ting Niu, Lin LIU, Huijing Wu, Keshu Zhou, Wei Yang, Li Wang, Shu Cheng, Jie Wang, Jinrong Yang, Fei Li, Shiyong Zhou, Yanhong Tong, Ke Tan, Adrian Rui Liang, linyu yang, Lijuan Chen, Wei Li Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 5415.
https://doi.org/10.1182/blood-2025-5415
Published: 2025
Journal Articles

Preliminary analysis of a phase 2b, randomized, active-control study of flonoltinib maleate (FM) vs. ruxolitinib in intermediate-2 or high-risk myelofibrosis patients

Free
Lijuan Chen, Na Gao, Wei Yang, Qike Zhang, Hu Zhu, Zhihua Zhang, Lin LIU, Yong Wu, Jinxiao Yao, Zhenfang Liu, Zhenya Hong, Yanping Song, Xiaoyu Zhu, Jia Miao, Jinrong Yang, Ke Tan, Adrian Rui Liang, Zefeng Xu, Ting Niu, Zhijian Xiao
Journal: Blood
Blood (2025) 146 (Supplement 1): 908.
https://doi.org/10.1182/blood-2025-908
Published: 2025